Clinical trial Recruiting at 2 sites Phase2; Phase3 Interventional Ages 18 to 35

Using MRI to Measure Lung Damage in Young E-cigarette Users

Official title: Dissolved Phase Hyperpolarized Xenon-129 MRI: a Novel Biomarker to Quantify Pulmonary Pathology in Healthy Participants and E-cigarette Users

Run by University of Virginia · NCT06856525 · Data updated 2026-11-12

This study is trying to see how using e-cigarettes affects lung health and fitness in young people by comparing them to those who don’t use e-cigarettes over a year.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Virginia
Academic / other
Locations2 sites (Durham, North Carolina and 1 other locations)
StatusRecruiting
StartedDecember 19, 2024
Main results expectedDecember 31, 2028
Study endsDecember 31, 2032
Registry record updatedMarch 17, 2026
Trial IDNCT06856525 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy young adults aged 18 to 35 who have been using e-cigarettes regularly for over six months.

Probably not a fit

Patients with a history of lung disease or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study involves a longitudinal assessment of 40 young electronic cigarette users and 40 healthy controls to evaluate the impact of e-cigarette use on lung function. Participants will undergo hyperpolarized xenon-129 MRI and cardiopulmonary stress tests at the beginning and after 12 months. The goal is to quantify changes in pulmonary gas exchange capacity and physical fitness related to e-cigarette use. The study aims to provide insights into the early effects of vaping on lung health.

Why it matters

Potential benefit: If successful, this study could help identify early lung damage in young e-cigarette users, leading to better prevention and treatment strategies.

How similar studies have gone: While there is emerging research on the effects of e-cigarettes, this specific approach using hyperpolarized xenon-129 MRI is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Ages between 18 and 35 years old.
2. At their baseline health
3. Ability to understand a written informed consent form and comply with the requirements of the study.
4. Exclusive long-term, recent, and greater than six months continuous e-cigarette use with greater than three days a week frequency.
5. Users of "closed-container" and "pre-packaged" electronic cigarette juices that must contain nicotine.
6. Healthy subjects must be at baseline normal spirometry with or without bronchodilator, plethysmograph lung volume, DLCO, and 6-minute walk by ATS/ERS with Global Lung Initiative Reference. (PFT will be completed during a screening visit); Ecigarette users can have normal spirometry (FEV1/FVC\>70) or abnormal spirometry (FEV1/FVC 26-70)

   \-

Exclusion Criteria:

1. History of any other lung disease
2. History of brain diseases including stroke (CNS) and dementia, end-stage liver disease, coronary artery disease, renal failure
3. Acute infection of any kind previous 6 weeks
4. Pregnancy or a possibility of pregnancy
5. Anemia
6. Inability to undergo PFT, CPET, or MR imaging (usual clinical standard criteria for MRI)
7. Prior cigarette smoking of greater than one pack-year within six months before enrolling in the study.
8. Using a non-closed container, custom-made electronic cigarette juice, or inability for the study team to access "closed-container" and "pre-packaged" electronic cigarette juice for chemical analysis

Where it's running

  • Duke University
    Durham, North Carolina, United States
    Recruiting
  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting

Study contacts

  • Principal investigator: Yun M Shim, MD — University of Virginia
  • Study coordinator: Roselove Asare, MA
  • Email: rnn3b@virginia.edu
  • Phone: 4342436074

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.